Real Isolates
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
48 Dunham Rd Ste 5750, Beverly, Massachu...Website
www.smokenol.comRevenue
<$5 MillionIndustry
About Real Isolates
When two compounds interact to form a larger therapeutic effect than would be expected separately, they are called synergistic. Most negative side effects are a result of having large doses present in the body (overloading target systems or interacting with off-targets at high concentrations); synergy by formulation allows the total dosage to be reduced while maintaining the desired therapeutic effect. "Cannabis saved my life. I believe in the molecular basis of Cannabis as a valid therapeutic option for chronic neurological, inflammatory, and autoimmune disorders." Dr. Shields is a biochemist who specializes in the endocannabinoid system (ECS); their research began in 2010, the same year they received their prescription in medical Cannabis. From 2010-2012 they evaluated drugs that act downstream of the ECS in animal models at UC Davis . From 2012-2018 they pursued their PhD at Northeastern University investigating synthetic cannabinoids for the treatment of opioid addiction, but the pRead more
SIC Code 87,873NAICS Code 54,541Show moreReal Isolates Org Chart
Real Isolates Tech Stack
A closer look at the technologies used by Real Isolates
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Real Isolates
Sign Up For FreeTo access detailed company insights
When two compounds interact to form a larger therapeutic effect than would be expected separately, they are called synergistic. Most negative side effects are a result of having large doses present in the body (overloading target systems or interacting with off-targets at high concentrations); synergy by formulation allows the total dosage to be re... Read More